Dublin The Odds: Ireland Plays On Strengths As It Prepares EMA Bid
Ireland’s health minister says the country is preparing to launch a formal bid to host the European Medicines Agency following the UK’s decision to quit the EU, claiming it can offer an “excellent track record” in regulating medicines and medical devices, a proactive drugs agency, and a “thriving” pharmaceutical sector.
You may also be interested in...
Ireland’s healthcare products regulator HPRA says it is taking steps to deal with possible supply interruptions as a result of Brexit, and that it is ready to assume some of the regulatory workload that will result from the European Medicines Agency’s departure from the UK. A stakeholder workshop will be held at the end of August where pharma firms and distributors will be able to discuss Brexit-related concerns with the regulator.
The UK is on track to start formal EU exit negotiations in March, Denmark has announced its official candidacy to host the European Medicines Agency post-Brexit, and details are emerging on the campaigns that other contenders for the EMA, such as Ireland and Italy, are waging.
The assumption to date has been that the European Medicines Agency will have to move from its London base when the UK leaves the EU. But things may not be quite that simple.